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dependent on a pathway that includes
TNK2, WASL, and NCK1
Hongbing Jiang*, Christian Leung, Stephen Tahan, David Wang*
Department of Molecular Microbiology, Pathology and Immunology, School of
Medicine, Washington University, St. Louis, United States
Abstract Comprehensive knowledge of the host factors required for picornavirus infection
would facilitate antiviral development. Here we demonstrate roles for three human genes, TNK2,
WASL, and NCK1, in infection by multiple picornaviruses. CRISPR deletion of TNK2, WASL, or
NCK1 reduced encephalomyocarditis virus (EMCV), coxsackievirus B3 (CVB3), poliovirus and
enterovirus D68 infection, and chemical inhibitors of TNK2 and WASL decreased EMCV infection.
Reduced EMCV lethality was observed in mice lacking TNK2. TNK2, WASL, and NCK1 were
important in early stages of the viral lifecycle, and genetic epistasis analysis demonstrated that the
three genes function in a common pathway. Mechanistically, reduced internalization of EMCV was
observed in TNK2 deficient cells demonstrating that TNK2 functions in EMCV entry. Domain
analysis of WASL demonstrated that its actin nucleation activity was necessary to facilitate viral
infection. Together, these data support a model wherein TNK2, WASL, and NCK1 comprise a
pathway important for multiple picornaviruses.
Introduction
Picornaviruses cause a wide range of diseases including the common cold, hepatitis, myocarditis,
poliomyelitis, meningitis, and encephalitis (Melnick, 1983). Although vaccines exist for poliovirus
and hepatitis A virus, there are currently no FDA approved antivirals against picornaviruses in the
United States. As obligate intracellular pathogens, viruses are dependent on the host cellular
machinery to complete their lifecycle. The early stages of the virus lifecycle, including receptor bind-
ing, entry, uncoating, and initiation of replication, are the ideal targets for preventing virus infection
since the virus has not yet multiplied.
Despite extensive studies (Yamauchi and Helenius, 2013), there remain significant gaps in our
understanding of virus entry. As the family Picornaviridae encompasses a wide range of viruses, it is
not surprising that there is diversity in the known entry mechanisms of different species. Among the
picornaviruses, poliovirus entry has been the most extensively studied. While some reports suggest
that poliovirus enters the cell through clathrin-mediated endocytosis and that its genome release
depends on endosome acidification (Madshus et al., 1984a), more recent studies report that polio-
virus enters cells by a clathrin-, caveolin-, flotillin-, and microtubule-independent pathway
(Brandenburg et al., 2007). Furthermore, poliovirus entry is sensitive to inhibitors of both tyrosine
kinases and actin-polymerization, although it is not known which specific tyrosine kinase(s) is/are
important for poliovirus infection (Brandenburg et al., 2007). Coxsackie virus B3 (CVB3) entry has
also been extensively studied (Bergelson and Coyne, 2013). In polarized epithelial cells, CVB3 bind-
ing to the co-receptor decay-accelerating factor (DAF) and the coxsackievirus and adenovirus recep-
tor (CAR) leads to entry by caveolin-dependent endocytosis and macropinocytosis (Coyne and
Bergelson, 2006; Coyne et al., 2007). In contrast to CVB3 and poliovirus, there have been few stud-
ies of EMCV entry. Vascular cell adhesion molecule 1 (VCAM-1) and the disintegrin and
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metalloproteinase domain-containing protein 9 (ADAM9) are reported to be entry factors for EMCV
(Huber, 1994; Bazzone et al., 2019; Baggen et al., 2019). Interaction of the EMCV virion with
VCAM-1 is believed to induce a conformational change that then releases the viral RNA genome;
entry into the cytosol is reported to be independent of acidification (Madshus et al., 1984b).
Using a novel virus infection system comprised of the model organism C. elegans and Orsay virus,
the only known natural virus of C. elegans, we previously identified several genes that are essential
for virus infection in C. elegans (Jiang et al., 2017). The genes sid-3, viro-2 and nck-1 were found to
be essential for an early, pre-replication step of the Orsay virus lifecycle. sid-3 encodes a non-recep-
tor tyrosine kinase orthologous to human Tyrosine Kinase Non-Receptor 2 (TNK2), viro-2 encodes an
orthologue of human Wiskott-Aldrich Syndrome protein Like protein (WASL), and nck-1 encodes an
orthologue of Non-Catalytic Region of Tyrosine Kinase (NCK1), an adaptor protein that binds to
both TNK2 and WASL (Galisteo et al., 2006; Donnelly et al., 2013). Since Orsay virus is a non-
enveloped, positive strand RNA virus that is evolutionarily related to the family Picornaviridae, we
reasoned that the human orthologues of these genes may have a conserved role in infection by
picornaviruses.
Human TNK2 is linked to cancers, has been reported to be activated by multiple extracellular
stimuli, and is involved in many different pathways, such as clathrin/receptor mediated endocytosis,
regulation of EGFR degradation, transduction of signals into the nucleus, and regulation of actin
polymerization (Galisteo et al., 2006; Liu et al., 2010; Mahajan et al., 2005; Yokoyama et al.,
2005). Furthermore, overexpression of TNK2 induces interferon and leads to reduced replication of
a Hepatitis C virus replicon (Fujimoto et al., 2011). To date, there are no publications demonstrat-
ing a positive role for TNK2 in virus infection; several siRNA-based screens suggest that TNK2 is
important for influenza A virus (IAV), vesicular stomatitis virus (VSV), and hepatitis C virus (HCV) infec-
tions (Fujimoto et al., 2011; Ko¨nig et al., 2010; Karlas et al., 2010; Lupberger et al., 2011), but
no validation of these screening results have been reported. Humans encode two orthologues of
viro-2, WASP and WASL (Wiskott-Aldrich syndrome protein /-like) (Massaad et al., 2013). Strikingly,
biochemical assays have demonstrated that WASL is a substrate for the kinase activity of TNK2
(Yokoyama et al., 2005), suggesting that the two function in a pathway. NCK1 is an adaptor protein
reported to co-localize with TNK2 (Galisteo et al., 2006; Teo et al., 2001) and interact with WASL.
There are only limited studies linking WASL and NCK1 to virus infection. A clear role has been estab-
lished for WASL in spread of vaccinia virus (Frischknecht et al., 1999) that involves NCK1 as well
(Donnelly et al., 2013; Dodding and Way, 2009). Furthermore, sensitivity of Lassa virus infection to
Wiskostatin, a small molecule inhibitor of WASL, suggests a role of WASL in virus entry
(Oppliger et al., 2016). However, there are no studies implicating NCK1 in any aspect of picornavi-
rus infection or in entry of any virus.
Here, we determined whether these three human orthologues of the genes found in a C. elegans
forward genetic screen function in an evolutionarily conserved manner to facilitate virus infection in
human cell culture. CRISPR-Cas9 genome editing was used to generate knockout cells for each
gene, and their impact on infection by a panel of viruses from different families was then tested. Sig-
nificant reductions in infection by multiple picornaviruses were observed in each of the cell lines.
Consistent with these in vitro data, we observed increased survival of mice lacking murine TNK2
after EMCV challenge in vivo. We further demonstrated that TNK2, WASL, and NCK1 function in a
pathway to support EMCV virus infection with WASL and NCK1 lying downstream of TNK2. Mecha-
nistically, loss of TNK2 led to reduced EMCV virus internalization, while both TNK2 and WASL were
required for proper endocytic trafficking of EMCV. These data support a model wherein TNK2,
WASL, and NCK1 comprise a pathway that is important for entry by multiple picornaviruses.
Results
Non-receptor tyrosine kinase TNK2 is important for infection by
multiple picornaviruses
To investigate the function of TNK2 in virus infection, human lung epithelial carcinoma A549 cells
deficient in TNK2 were generated by CRISPR-Cas9 genome editing (Figure 1A). We tested a panel
of viruses, including multiple viruses from the family Picornaviridae, which are evolutionarily related
to Orsay virus (Wolf et al., 2018). In a single step growth analysis, deletion of TNK2 by two
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independent sgRNAs (TNK2 KO1 and TNK2 KO2 cells) reduced EMCV infection by 93% and 86%,
respectively, compared to control cells (p<0.00001, Figure 1B and Figure 1—figure supplement
1A). When infected by CVB3, 56% and 48% fewer infected TNK2 KO1 and TNK2 KO2 cells were
observed (p<0.0001, Figure 1D and Figure 1—figure supplement 1B). In a multi-step growth
curve, EMCV titers in the supernatant from TNK2 KO1 were 1660-fold lower at 24 hr post infection
(p<0.01, Figure 1C) and CVB3 titers in the supernatant from the TNK2 KO1 were 154-fold lower at
36 hr post infection (p<0.01, Figure 1E). In addition, reduced infectivity in TNK2 KO1 was also
Figure 1. TNK2 is critical for multiple picornavirus infections. (A) TNK2 protein expression in TNK2 KO1, TNK2
KO2, and Ctrl (control) cells generated by CRISPR-Cas9 genome editing with either specific targeting or non-
specific targeting sgRNA in A549 cells. Cells lysates were analyzed by Western blot. (B) FACS quantification of
EMCV positive cells for TNK2 KO1, TNK2 KO2, and Ctrl cells 10 hr post infection at an MOI of 1. (C) Multi-step
growth curve for EMCV multiplication on TNK2 KO1 and Ctrl cells at an MOI of 0.01. Virus titers in the culture
supernatant were quantified by plaque assay at 0, 6, 12, 24, 36, and 48 hr post infection. (D) FACS quantification of
CVB3 virus positive cells for TNK2 KO1, TNK2 KO2, and Ctrl cells 8 hr post infection at an MOI of 1. (E) Multi-step
growth curve for CVB3 multiplication on TNK2 KO1 and Ctrl cells at an MOI of 0.01. Virus titers in the culture
supernatant were quantified by plaque assay at 0, 6, 12, 24, 36, and 48 hr post infection. (F) Aim-100 inhibition of
EMCV infection on naı¨ve A549 cells. A549 cells were pre-treated with Aim-100 at indicated concentrations and
infected with EMCV at an MOI of 1. Virus positive cells were quantified by FACS. (B, D, F) Error bars represent
standard deviation of three replicates. The data shown are representatives of three independent experiments. *:
p<0.05, ***: p<0.001, ****: p<0.0001, *****: p<0.00001.
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. Source data for Figure 1B, D and F: FACS quantification of virus infected cells.
Figure supplement 1. TNK2 is critical for multiple picornavirus infections.
Figure supplement 2. TNK2 and WASL are critical for multiple picornavirus infection on A549 cells.
Figure supplement 3. TNK2 and WASL are critical for multiple picornavirus infection on both A549 and Hap1
cells.
Figure supplement 4. EMCV virus infection of TNK2 rescue on knockout and control cells.
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observed with both recombinant GFP-EMCV and GFP-CVB3, respectively (Figure 1—figure supple-
ment 2A B). Furthermore, we examined virus replication complex formation by double stranded
RNA immunostaining with the commercial J2 antibody and direct electron microscopy (EM) on
EMCV-infected cells. We observed fewer cells positive for double-stranded RNA and smaller size of
the virus replication complex (Figure 1—figure supplement 2C D). To corroborate these findings,
we analyzed EMCV and CVB3 infection in commercial Hap1 cells (a haploid hematopoietic-derived
lymphoma cell line) deficient in TNK2. Reductions in infected cells by 24% for EMCV and 30% for
CVB3 were observed (p<0.001, Figure 1—figure supplement 3A B). Statistically significant reduc-
tions in poliovirus infection in both Hap1 and A549 TNK2 knockout cells and reduction in enterovirus
D68 infection in A549 cells were also observed (Figure 1—figure supplement 3C, E F). In contrast,
no effect of TNK2 deletion was seen for IAV, parainfluenza virus (PIV5) or adenovirus 5 (Figure 1—
figure supplement 3D, G, H I), demonstrating the apparent specificity of TNK2 for picornavirus
infection.
We next attempted to rescue the EMCV infection defect in TNK2 knockout cells by ectopic over-
expression of TNK2. However, the complexity of the TNK2 locus (three major isoforms and 22 puta-
tive transcript variants; Zerbino et al., 2018) presented challenges, and the reported induction of
interferon by TNK2 overexpression (Fujimoto et al., 2011) may have further complicated interpreta-
tion of these experiments. Lentivirus expression of each of the three major TNK2 isoforms (which
yielded expression levels of TNK2 much higher than the endogenous levels (Figure 1—figure sup-
plement 4D)) in control A549 cells led to statistically significant reductions in EMCV infection (Fig-
ure 1—figure supplement 4A, B C). In addition, fluorescently tagged TNK2 expression through
either direct transfection in 293 T cells or lentivirus transduction in A549 cells led to aggregates
inside the cytosol (Figure 3—figure supplement 1 and Figure 5—figure supplement 1A). Never-
theless, we consistently observed a small, but statistically significant increase in EMCV virus infection
in TNK2 KO1 cells transduced with the canonical isoform one as compared to the control cells (Fig-
ure 1—figure supplement 4A). We also used an alternative approach to rescue virus infection in
TNK2 KO1 cells by reverting the 28 bp deletion in clone TNK2 KO1 using CRISPR-Cas9 with oligonu-
cleotide-mediated homologous template-directed recombination (HDR); three synonymous muta-
tions were included in the template to unambiguously identify a successful repair event (Figure 1—
figure supplement 4H). Screening of 500 single-cell clones yielded one clone that had repaired the
TNK2 28 bp deletion allele. However, this process also introduced an insertion of 11 nucleotides in
the adjacent intron sequence 9 bp from the nearby splice acceptor (Figure 1—figure supplement
4H). We were able to restore low levels of TNK2 expression in the HDR repaired clone (Figure 1—
figure supplement 4G). In this clone, EMCV infected cell percentage and virus titer increased, by 8-
fold (p<0.0001, Figure 1—figure supplement 4E) and 9-fold (p<0.01, Figure 1—figure supplement
4F), respectively as compared to TNK2 KO1 cells.
As a completely independent means of assessing the role of TNK2, we treated A549 cells with
Aim-100, a small molecule kinase inhibitor with specificity for TNK2 (Mahajan et al., 2010). Aim-100
pre-treatment reduced EMCV infection in a dose dependent manner without affecting cell viability
(Figure 1F, Figure 1—figure supplement 1C and data not shown).
WASL, a known substrate of TNK2, is important for picornavirus
infection
The human genome encodes two WASP paralogues, WASP and WASL (also known as N-WASP). In
this study, we focused on WASL because WASP is not expressed in epithelial cells such as A549.
Clonal WASL knockout A549 cells were generated by CRISPR-Cas9 genome editing (Figure 2A). In
a single step growth analysis, WASL KO cells showed 62% reduction in EMCV-infected cells as com-
pared to control cells (p<0.0001, Figure 2B and Figure 2—figure supplement 1A), while in a multi-
step growth curve, WASL KO cells yielded 248-fold reduced virus titers at 24 hr post infection
(p<0.01, Figure 2C). Ectopic expression of WASL in the WASL KO cells rescued EMCV infection to
wild type levels (Figure 2—figure supplement 2A B). As with TNK2, we observed fewer cells posi-
tive for double stranded RNA by immunostaining and smaller size of the virus replication complex
by EM (Figure 1—figure supplement 2C D). Reduced levels of CVB3, poliovirus, and enterovirus
D68 infection were observed in these cells (Figure 2D and E, Figure 1—figure supplement 3E, F).
In addition, independent Hap1 cells deficient in WASL had reduced EMCV, CVB3 and poliovirus
infection (Figure 1—figure supplement 3A, B C). To independently assess the role of WASL during
Jiang et al. eLife 2019;8:e50276. DOI: https://doi.org/10.7554/eLife.50276 4 of 29
Research article Microbiology and Infectious Disease
Figure 2. WASL and NCK1 are critical for multiple picornavirus infections. (A) WASL protein expression in WASL
KO and Ctrl cells generated by CRISPR-Cas9 genome editing with either specific targeting or non-specific
targeting sgRNA in A549 cells. Cells lysates were analyzed by Western blot. (B) FACS quantification of EMCV
positive cells for WASL KO and Ctrl cells 10 hr post infection at an MOI of 1. (C) Multi-step growth curve for EMCV
multiplication on WASL KO and Ctrl cells infected at an MOI of 0.01. (D) FACS quantification of CVB3 positive cells
for WASL KO and Ctrl cells 8 hr post infection at an MOI of 1. (E) Multi-step growth curve for CVB3 multiplication
on WASL KO and Ctrl cells infected at an MOI of 0.01. (F) Wiskostatin inhibition of EMCV infection on naı¨ve A549
cells. A549 cells were pre-treated with Wiskotstatin at indicated concentrations and infected with EMCV at an MOI
of 1. Virus positive cells were quantified by FACS. (G) NCK1 protein expression in NCK1 KO and Ctrl cells
generated by CRISPR-Cas9 genome editing with either specific targeting or non-specific targeting sgRNA in A549
cells. Cells lysates were analyzed by Western blot. (H) FACS quantification of EMCV positive cells for NCK1 KO
and Ctrl cells 10 hr post infection at an MOI of 1. (I) Multi-step growth curve for EMCV multiplication on NCK1 KO
and Ctrl cells infected at an MOI of 0.01. (J) FACS quantification of CVB3 positive cells for NCK1 KO and Ctrl cells
8 hr post infection at an MOI of 1. (K) Multi-step growth curve for CVB3 multiplication on NCK1 KO and Ctrl cells
infected at an MOI of 0.01. (A) The red asterisk indicates WASL protein band. (B, D, F, H, J) Error bars represent
standard deviation of three replicates. The data shown are representatives of at least two independent
experiments. **: p<0.01, ***: p<0.001, ****: p<0.0001, *****: p<0.00001, NS: not significant (p>0.05).
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Source data 1. Source data for Figure 2B, D, F, H and J: FACS quantification of virus infected cells.
Figure supplement 1. WASL and NCK1 are critical for multiple picornavirus infections.
Figure supplement 2. EMCV infection of WASL and NCK1 rescued knock out cells.
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virus infection, we used a small molecule inhibitor of WASL, Wiskostatin (Peterson et al., 2004). Wis-
kostatin reduced EMCV infection in A549 cells in a dose-dependent manner with no apparent
decrease of cell viability (Figure 2F, Figure 2—figure supplement 1C and data not shown). These
data demonstrate that WASL is important for multiple picornavirus infection in human cell culture.
The signaling adaptor protein NCK1 is also important for picornavirus
infection
Deletion of NCK1 in A549 cells (Figure 2G) reduced the number of EMCV and CVB3 infected cells
by 55% and 49%, respectively (p<0.0001, Figure 2H and J, Figure 2—figure supplement 1D E)
comparable to the reductions observed in WASL KO cells. By a multi-step growth analysis, NCK1
KO showed 10-fold reduction of EMCV virus titer at 24 hr post infection (P<0.01 Figure 2I) and 14-
fold reduction of CVB3 titer at 36 hr post infection (p<0.05, Figure 2K). Ectopic expression of NCK1
in the NCK1 KO cells rescued EMCV infection to wild type levels (Figure 2—figure supplement 2C
D). As with TNK2 and WASL, these data demonstrate that NCK1 is important for multiple picornavi-
rus infection in human cell culture.
TNK2, WASL, and NCK1 are components of a common pathway
To determine whether TNK2, WASL, and NCK1 act in a common or distinct pathway for virus infec-
tion, we performed genetic epistasis analysis by generating double and triple mutant cell lines (Fig-
ure 3—figure supplement 2A). EMCV infection levels and viral titer production in the double and
triple knockout lines were the same as observed in the TNK2 KO1 lines (Figure 3A and B and Fig-
ure 3—figure supplement 3A). The lack of an additive effect suggests that WASL and NCK1 are
both in the same genetic pathway as TNK2. Combined with the known ability of TNK2 to phosphory-
late WASL (Yokoyama et al., 2005), these data support a model where TNK2 acts upstream of
WASL and NCK1. The magnitude of the impact of TNK2 KO1 was greater than that of WASL KO or
NCK1 KO, suggesting that TNK2 might work through additional pathways in mediating virus infec-
tion besides acting through WASL and NCK1.
Because TNK2 phosphorylation of WASL increases its actin nucleation activity (Yokoyama and
Miller, 2003), we reasoned that it might be possible to complement the TNK2 deficiency by overex-
pression of WASL. Overexpression of wild type WASL in the TNK2 KO1 A549 cells led to increased
EMCV virus infection (Figure 3C). Since constitutively active point mutants of WASL have been
described (Adamovich et al., 2009; Keszei et al., 2018) (Figure 3—figure supplement 2B C), we
next tested whether overexpression of three such constructs in the TNK2 KO1 cells could further
increase virus infection. A higher level of complementation for all three mutants was observed com-
pared to wild type WASL (Figure 3C, Figure 3—figure supplement 3B). For NCK1, based on its
reported binding to WASL and TNK2, we hypothesized that its function is to recruit WASL to TNK2,
which could then activate WASL via phosphorylation (Yokoyama et al., 2005; Rohatgi et al., 2001).
Thus, we also tested whether constitutively active WASL could complement NCK1 KO. Constitutively
active WASL fully rescued the NCK1 KO virus infection phenotype (Figure 3D and Figure 3—figure
supplements 2D, 3C). Together, these data demonstrated that TNK2, WASL, and NCK1 are in a
pathway to support picornavirus infection with WASL and NCK1 downstream of TNK2.
We further evaluated the interactions between TNK2, WASL and NCK1 using biochemical and
biophysical assays. Previous studies had reported interaction between NCK1 and WASL through far
Western and pull-down assay (Donnelly et al., 2013) and co-localization of TNK2 and NCK1 through
protein overexpression (Galisteo et al., 2006). Fluorescent protein tagged forms of TNK2, WASL,
and NCK1 were individually expressed in 293 T cells. WASL and NCK1 both distributed homoge-
nously throughout the cytoplasm, while TNK2 formed puncta in the cytoplasm (Figure 3—figure
supplement 1), which agreed with previous observations (Teo et al., 2001; Shen et al., 2011). To
examine potential co-localization, we co-expressed either mCerulean tagged TNK2 or mCerulean
tagged WASL with mVenus tagged NCK1 in 293 T cells, respectively. Since NCK1 is an adaptor pro-
tein, we reasoned that its interactions with binding partners would likely be relatively stable and
therefore more readily detectable. Co-expression of mCerulean tagged TNK2 with mVenus tagged
NCK1 re-localized NCK1 into the puncta observed by TNK2 expression alone (Figure 3—figure sup-
plements 1, 4A). Co-expression of mCerulean tagged WASL with mVenus tagged NCK1 showed
homogenous distribution in the cytoplasm and co-localization of these two proteins (Figure 3—
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figure supplements 1, 4A). Further analysis by quantitative FRET demonstrated that WASL and
NCK1 had higher FRET efficiency in cells, while TNK2 and NCK1 also had significant, but lower,
FRET efficiency (Figure 3—figure supplement 4A B). Consistent with the FRET data, in co-trans-
fected 293 T cells, immunoprecipitation of FLAG tagged NCK1 pulled down HA tagged WASL more
efficiently than it did Myc tagged TNK2 (Figure 3—figure supplement 4C). Altogether, these data
demonstrate that TNK2 and WASL bind directly to NCK1.
TNK2, WASL, and NCK1 affect a pre-replication step of the EMCV
lifecycle
To begin dissecting the stage of the EMCV virus lifecycle impacted by TNK2, WASL, and NCK1, we
transfected EMCV genomic RNA into the cells to bypass the early stages of the viral lifecycle. The
TNK2 KO1, WASL KO, and NCK1 KO cells produced the same titers of EMCV virus as the control
cells at 10 hr post transfection (Figure 4A) demonstrating that TNK2, WASL, and NCK1 are dispens-
able for EMCV replication and post-replication stages of the EMCV lifecycle. Thus, we concluded
that all three genes act on an early stage of the viral lifecycle. As a second line of evidence, we
determined the impact of adding the TNK2 kinase-specific inhibitor Aim-100 before or at varying
times after EMCV infection. While Aim-100 pre-treatment reduced EMCV infection, administration
Figure 3. TNK2, WASL, and NCK1 are in a pathway supporting virus infection. (A) FACS quantification of EMCV
positive cells for TNK2, WASL, NCK1 single, double, triple gene knockout and Ctrl cells 10 hr post infection at an
MOI of 1. (B) Virus titer for EMCV multiplication on TNK2, WASL, and NCK1 single, double, triple gene knockout
and Ctrl cells at 24 hr post infection at an MOI of 0.01. (C) FACS quantification of EMCV positive cells for TNK2
KO1 cells that were transduced with constitutively active WASL constructs 10 hr post infection at an MOI of 1. (D)
FACS quantification of EMCV positive cells for NCK1 KO cells that were transduced with constitutively active
WASL constructs 10 hr post infection at an MOI of 1. (A, B) dko: double knockout, tko: triple knockout. (A–D) Error
bars for virus infection represent standard deviation of three replicates. The data shown are representatives of two
independent experiments.
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. Source data for Figure 3A, C and D: FACS quantification of virus infected cells.
Figure supplement 1. Co-localization of fluorescently tagged NCK1, TNK2, and WASL expressed in 293 T cells by
confocal imaging.
Figure supplement 2. Gene expression in knock out cells and constitutively active WASL expression.
Figure supplement 3. TNK2, WASL, and NCK1 are in a pathway supporting virus infection.
Figure supplement 4. TNK2 and WASL directly interact with NCK1.
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Figure 4. TNK2, WASL, and NCK1 function at an early stage of virus lifecycle. (A) EMCV released from viral RNA
transfected Ctrl, TNK2 KO1, WASL KO, and NCK1 KO cells 10 hr post transfection was quantified by plaque assay.
(B) Time-dependent addition of Aim-100 on EMCV infection on naı¨ve A549 cells. A549 cells were treated with 3.2
mM Aim-100 at different time points before and after EMCV infection at an MOI of 1. EMCV positive cells were
then quantified by FACS. (C) Quantification of EMCV virus binding on TNK2 KO1 and WASL KO cells by qRT-PCR
expressed as relative change to Ctrl cell binding. (D) Quantification of EMCV virus internalization in TNK2 KO1 and
WASL KO cells by qRT-PCR expressed as relative change to Ctrl cell internalization. (E) FACS quantification of
labeled EMCV internalization in TNK2 KO1, WASL KO and Ctrl cells. (F) a-sarcin pore forming assay performed on
TNK2 KO1, WASL KO and Ctrl cells. Translation was measured by phosphorimaging of 35S-methionine/cysteine
incorporation. (G) eIF4G cleavage by CVB3 infection for 2 hr with or without 2 mM guanidine hydrochloride. (A–E)
Error bars represent standard deviation of three replicates. The data shown are representative of two independent
experiments. ***: p<0.001, ****: p<0.0001, NS: not significant (p>0.05).
Figure 4 continued on next page
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after virus inoculation had no effect (Figure 4B and Figure 4—figure supplement 1), consistent
with a role for TNK2 at an early stage of virus infection.
TNK2, but not WASL functions in virus internalization
We examined the impact of TNK2 and WASL deletion on virus binding, virus internalization, pore
formation, and viral RNA genome translocation. Following incubation at 4˚C for one hour, no differ-
ence in virus binding was observed among control, TNK2 KO1, and WASL KO cells (Figure 4C), as
assessed by qRT-PCR for EMCV genomic RNA. In contrast, after raising the temperature to 37˚ C for
30 min to allow for internalization of the bound virus particles and then trypsinization to remove
uninternalized surface virus particles as described before (Berry and Tse, 2017; Hackett et al.,
2015), there was a 46% reduction (p<0.001) of intracellular EMCV viral RNA in the TNK2 KO1 cells
(Figure 4D and Figure 4—figure supplement 2C–E). However, no difference in RNA levels was
observed in WASL KO cells (Figure 4D). As a complementary approach, we evaluated internalization
using fluorescently labeled EMCV virions (Figure 4—figure supplement 2A B). 25% fewer EMCV
positive TNK2 KO1 cells were observed compared to control cells (Figure 4E and Figure 4—figure
supplement 2B), while no statistical difference was observed in the WASL KO cells (Figure 4E and
Figure 4—figure supplement 2B).
We examined the ability of fluorescently labeled transferrin, a known cargo for clathrin-mediated
endocytosis, to be endocytosed in both TNK2 KO1 and WASL KO cells. Transferrin was internalized
in TNK2 KO1 and WASL KO cells to the same level as in the control cells (Figure 4—figure supple-
ment 3A B), consistent with a previous report that knock down of TNK2 has no effect on transferrin
endocytosis (Grøvdal et al., 2008). To further check other general virus entry pathways, we also
examined whether macropinocytosis was affected in these cells. FITC conjugated Dextran (7 KDa) is
reported to be uptaken by macropinocytosis (Oppliger et al., 2016). No defect in uptake of Dextran
was observed in TNK2 KO1 cells (Figure 4—figure supplement 3C D). In contrast, the WASL KO
cells had a 75% reduction in Dextran uptake (Figure 4—figure supplement 3C D), which is consis-
tent with the known dependency of macropinocytosis on actin polymerization (Innocenti et al.,
2005). The Dextran macropinocytosis defect in the WASL KO appears to be unrelated to EMCV
infection though since no reduction in either binding or internalization of EMCV was observed.
A step that is closely linked to internalization for picornaviruses is virus-induced pore formation,
which is required for genome release into the cytoplasm. To assess pore formation, cells were
treated with the membrane impermeable translation inhibitor, a-sarcin. Virus-induced pore forma-
tion will lead to translation inhibition and reduction of 35S methionine and 35S cysteine incorporation
whereas in the absence of pore formation, translation will proceed at wild type levels (Ferna´ndez-
Puentes and Carrasco, 1980). TNK2 KO1 and WASL KO cells showed no defect in virus pore forma-
tion during EMCV infection (Figure 4F). Although a clear defect in EMCV internalization exists in the
TNK2 KO1 cells (Figure 4D and E), no defect in pore formation was observed. Since the internaliza-
tion defect in TNK2 KO1 cells is not absolute, pore formation may still occur with sufficient frequency
to inhibit translation. Alternatively, pore formation may not necessarily require prior internalization;
for example binding of parainfluenza virus alone is sufficient to initiate pore formation at the cell
membrane (Porotto et al., 2012). For WASL, no defect in binding, internalization or pore formation
was observed in the knockout cells, suggesting that the defect is downstream of these steps. Simi-
larly, a recent report suggests that the human gene PLA2G16 acts at a step of the picornavirus life-
cycle that is subsequent to pore formation (Staring et al., 2017).
To determine whether TNK2 or WASL plays any role in downstream viral RNA genome transloca-
tion after pore formation, we examined virus-induced host protein cleavage after its entry. For some
picornaviruses, immediately after translocation of its genome, translation of the incoming positive
Figure 4 continued
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Source data for Figure 4B: FACS quantification of virus infected cells.
Figure supplement 1. TNK2, WASL, and NCK1 function at an early stage of virus lifecycle.
Figure supplement 2. EMCV internalization in Ctrl, TNK2 KO1 and WASL KO cells.
Figure supplement 3. Transferrin, and dextran uptake in Ctrl, TNK2 KO1, and WASL KO cells.
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strand RNA leads to proteolytic cleavage of the host protein eIF4G to shut down host translation
(Glaser and Skern, 2000). Since this activity has not been described for EMCV, we used CVB3 which
is known to have this activity (Carthy et al., 1998). eIF4G cleavage in presence or absence of a virus
genome replication inhibitor guanidine hydrochloride showed no difference in the WASL KO cells as
compared to the control cells, demonstrating that WASL does not impact this step of the viral life-
cycle. In contrast, we observed a decrease of eIF4G cleavage in TNK2 KO1 cells, suggesting that
TNK2 might play a role in this process. Alternatively, the reduced eIF4G cleavage level might simply
reflect the reduced level of virus internalization in TNK2 KO1 cells (Figure 4G).
TNK2 was found in proximity to labeled EMCV particles during
infection
TNK2 is present in endocytic vesicles and colocalizes with the early endosome marker EEA1
(Teo et al., 2001; Shen et al., 2011; Grøvdal et al., 2008; Jones et al., 2014). To visualize TNK2
subcellular localization, we expressed N-terminally GFP tagged TNK2 in the TNK2 KO1 cells. Two
different patterns were observed in GFP positive cells: high TNK2 expression formed GFP aggre-
gates inside the cytosol of cells in about 80% of the cell population, which has been described previ-
ously (Teo et al., 2001; Prieto-Echagu¨e et al., 2010), and low TNK2 expression inside the cytosol of
cells in about 20% of the cell population (Figure 5—figure supplement 1A, B and C). Consistent
with the native TNK2 rescue, N-terminally GFP tagged TNK2 expression in the TNK2 KO1 cells sta-
tistically increased virus infection from 17.2% to 22.0% of GFP-transduced control cell infection
(p<0.01, Figure 5—figure supplement 1E). The modest increase was comparable to that observed
with ectopic expression of wild type TNK2. Next, we checked TNK2 localization in cells infected with
fluorescently labeled EMCV. In TNK2 KO1 cells with high TNK2 expression that formed aggregates,
no GFP-TNK2 in proximity to EMCV was observed (Figure 5—figure supplement 1A). However, in
cells with low TNK2 expression, labeled EMCV particles were observed in proximity to GFP-TNK2
(Figure 5A and Figure 5—figure supplement 1B), presumably in early endosomes. Further quantifi-
cation demonstrated that about 40% of the EMCV particles were in proximity to GFP-TNK2 in those
cells (Figure 5—figure supplement 1D).
WASL is recruited to vaccinia virus vesicles to promote its intracellular trafficking (Dodding and
Way, 2009). To examine whether EMCV infection recruits WASL as observed for poxvirus, we
expressed N-terminal GFP tagged WASL in WASL KO cells. The GFP tagged WASL was functional
as it rescued EMCV infection (Figure 5—figure supplement 1F). Following infection with fluores-
cently labeled EMCV, no clear recruitment of GFP-WASL to fluorescently labeled EMCV was
observed (Figure 5A).
EMCV infection is CDC42 dependent but clathrin independent
Both TNK2 and WASL are activated by the upstream CDC42 small GTPase (Galisteo et al., 2006;
Grøvdal et al., 2008; Howlin et al., 2008; Mahajan et al., 2007; Rohatgi et al., 2000), which can
be inhibited by pirl1 (Oppliger et al., 2016). Pirl1 treatment inhibited EMCV replication at a 10 mM
concentration without cell toxicity (Figure 5B, Figure 5—figure supplement 2 and data not shown),
suggesting that CDC42 mediates EMCV infection.
Since a role for TNK2 in clathrin-mediated endocytosis (CME) has been reported (Teo et al.,
2001), we next examined whether the classic CME inhibitors such as dynasore (a canonical inhibitor
of dynamin) or pitstop-2 (an inhibitor of clathrin) affect EMCV virus infection. Dynasore and pitstop-2
had no effect on EMCV infection while they inhibited VSV, a virus known to rely predominantly on
CME for its entry, in a dose dependent fashion (Figure 5—figure supplement 3A B). Together,
these data indicate that EMCV infection in A549 cells is dependent on CDC42, which activates TNK2
and WASL, but does not require CME for its entry.
EMCV virions accumulate in early endosomes in the absence of TNK2
or WASP
We next examined colocalization of EMCV with the early endosome marker EEA1. A time course
analysis demonstrated that in control cells, the peak colocalization of EMCV with EEA1 occurred at
20 min post internalization (Figure 5—figure supplement 3C D), which was followed by a decrease
at 30 min post internalization. This result is consistent with a previous report that poliovirus entry
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peaks at 20 min post infection (Brandenburg et al., 2007). In contrast, in both the TNK2 KO1 and
WASL KO cells, higher levels of EMCV particles were retained in EEA1 containing vesicles at 30 min
post internalization (Figure 5C, D, and Figure 5—figure supplement 3D). Thus, both TNK2 KO1
and WASL KO cells are characterized by increased accumulation of EMCV particles in early
endosomes.
EMCV infection is dependent on the activation of WASL and its actin
modulating function
The primary known effector function of WASL is nucleation of actin polymerization, which is medi-
ated by binding of its C-terminal domain to the Arp2/3 complex and actin monomers
(Galletta et al., 2008). Different domains of WASL are critical for interaction with other proteins that
Figure 5. TNK2 mediates virus infection through endosomal trafficking pathways. (A) Confocal imaging of GFP-
tagged TNK2 localization with fluorescently labeled EMCV virus in TNK2 KO1 cells and GFP-tagged WASL
localization with fluorescently labeled EMCV virus in WASL KO cells. Scale bars represent 10 mm. Individual
channels of different insets were shown. Scale bars represent 2 mm. (B) FACS quantification of EMCV infection on
pirl1 treated A549 cells at 10 hr post infection at an MOI of 1. Error bars represent standard deviation of three
replicates. (C) EEA1 staining of fluorescently labeled EMCV infected Ctrl, TNK2 KO1, and WASL KO cells. Scale
bars represent 20 mm. Insets represent magnification of the boxed region. Scale bars represent 5 mm. (D)
Quantification of Pearson correlation coefficient of EMCV and EEA1 colocalization in Ctrl, TNK2 KO1, and WASL
KO cells infected with fluorescently labeled EMCV. 33 cells for Ctrl, 37 cells for TNK2 KO1 and 19 cells for WASL
KO were quantified. Error bars represent standard deviation of images quantified. (B, D) The data shown are
representative of two independent experiments. *: p<0.05, **: p<0.01.
The online version of this article includes the following source data and figure supplement(s) for figure 5:
Source data 1. Source data for Figure 5B: FACS quantification of virus infected cells.
Figure supplement 1. Localization of GFP-TNK2 with fluorescently labeled EMCV.
Figure supplement 2. TNK2 mediates virus infection through endosomal trafficking pathways.
Figure supplement 3. The endocytosis pathway inhibition on EMCV infection and localization of EEA1 with
fluorescently labeled EMCV.
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can modulate WASL stability, activation, or function. Because ectopic expression of wild type WASL
fully rescued EMCV infection in WASL KO cells, we tested the ability of a series of WASL domain
deletion mutant constructs to rescue infection in WASL KO cells (Figure 6A). The basic region that
binds with PIP2, the proline rich region that binds with SH3 domain containing proteins, the GTPase
binding domain that interacts with CDC-42 kinase, and the acidic domain that is involved in actin
binding and polymerization were all required for EMCV infection (Figure 6B and C and Figure 6—
figure supplement 1A). Interestingly, transduction of the N-terminal WH1 domain truncated mutant
increased EMCV infection by 3-fold compared to wild type WASL transduction (Figure 6B and Fig-
ure 6—figure supplement 1A). The WH1 domain is reported to bind with WASP interacting pro-
teins (WIPs) to maintain WASL in an inactivated state (Stradal et al., 2004); therefore, the WH1
domain truncation mutant should have increased actin polymerization activity. To further assess the
WASL pathway’s role in EMCV infection, we treated cells with the Arp2/3 complex inhibitor CK-869.
CK-869 treatment inhibited EMCV infection in a dose-dependent manner without cell toxicity
(Figure 6D, Figure 6—figure supplement 1B and data not shown). Altogether, these data demon-
strated that WASL and its downstream actin pathway play important roles in EMCV infection.
TNK2 is required for EMCV infection in an in vivo mouse model
To investigate TNK2’s role in EMCV infection in vivo, we generated a Tnk2 knockout mouse that car-
ried a 13 Kb deletion of the murine Tnk2 genomic locus, which eliminated all annotated TNK2 iso-
forms and splice variants (Figure 7A). In primary mouse lung fibroblast cells, complete ablation of
TNK2 protein expression was observed by Western blot (Figure 7B). The number of cells infected
Figure 6. WASL activation and its actin modulation are critical for EMCV virus infection. (A) Schematic
representation of different WASL domain truncations. Each truncation is indicated by amino acid position on the
constructs. (B) FACS quantification of EMCV infection in WASL KO cells transduced with different WASL domain
truncations. (C) Western blot detection of WASL domain truncation expression constructs in lentivirus transduced
WASL KO cells. (D) CK-869 inhibition of EMCV infection on naı¨ve A549 cells at 10 hr post infection at an MOI of 1.
(B, D) Error bars represent standard deviation of three replicates. The data shown are representative of two
independent experiments. *: p<0.05, **: p<0.01, ***: p<0.001, ****: p<0.0001.
The online version of this article includes the following source data and figure supplement(s) for figure 6:
Source data 1. Source data for Figure 6B and D: FACS quantification of virus infected cells.
Figure supplement 1. WASL activation and its actin modulation are critical for EMCV virus infection.
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Figure 7. TNK2 is required for EMCV infection in vivo. (A) Schematic representation of Tnk2 knockout design by CRIPSR-Cas9 genome editing in
mouse. Exon, intron and genomic position are indicated. (B) TNK2 expression in mouse primary lung fibroblast cells derived from Tnk2 knockout and
wild type animals. Cell lysates were analyzed by Western blot. (C) FACS quantification of EMCV infection in mouse primary lung fibroblast cells derived
from Tnk2 knockout and wild type animals 6 hr post infection at an MOI of 1. Error bars represent standard deviation of three replicates. The data
shown are representative of two independent experiments. ***: p<0.001. (D) Multi-step growth of EMCV in mouse primary lung fibroblast cells from
Tnk2 knock out and wild type animals. *: p<0.05, **: p<0.01. (E) Survival curve of EMCV infection via oral gavage in Tnk2 knockout and wild type mice.
p=0.0051 by log-rank test. (F, G) EMCV titer in infected mouse brain and heart. *: p<0.05 by Mann-Whitney test, n = 16 for Tnk2 KO and n = 14 for WT.
The online version of this article includes the following source data and figure supplement(s) for figure 7:
Source data 1. Source data for Figure 7C, E, F, G.
Figure supplement 1. TNK2 is required for EMCV infection in vivo.
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by EMCV was reduced by 40% in the knockout cells (p<0.001, Figure 7C and Figure 7—figure sup-
plement 1). A multi-step growth analysis showed that wild type primary lung fibroblast had more
than 10-fold higher virus production than Tnk2 knock out cells at 6 hr post infection (p<0.01,
Figure 7D). In vivo, EMCV challenge with 107 PFU by oral gavage resulted in greater survival of
Tnk2 knockout animals compared to wild type animals (p=0.0051, Figure 7E). Virus titration in
infected mouse tissues showed that Tnk2 knock out mice had four logs lower virus titer in average in
brain and two logs lower virus titer in average in heart (p<0.05, Figure 7F and G). Together, these
data demonstrated an important role for TNK2 in EMCV infection in an in vivo mouse infection
model.
Discussion
We previously determined that the C. elegans genes sid-3, viro-2, and nck-1 are essential for Orsay
virus infection in C. elegans (Jiang et al., 2017). In this study, we further asked whether their respec-
tive human orthologues TNK2, WASL, and NCK1 play any roles in mammalian virus infection. After
screening a panel of mammalian viruses, we found that multiple picornaviruses, including EMCV,
CVB3, enterovirus D68, and poliovirus, rely on TNK2, WASL, and NCK1 for infection in different cell
lines. For TNK2, this represents the first evidence that it has any pro-viral function. Interestingly,
poliovirus entry was previously shown to be dependent on an unknown kinase based on the use of a
broad-spectrum tyrosine kinase inhibitor (Brandenburg et al., 2007). One possibility is that TNK2
might be the kinase targeted in that study.
Our data represent the first demonstration that WASL and NCK1 are important for infection by
picornaviruses such as EMCV, CVB3, enterovirus D68, and poliovirus. RNA transfection of EMCV into
TNK2, WASL, and NCK1 knockouts each yielded the same level of virus as the control demonstrating
their role in an early stage of the EMCV lifecycle. For WASL, this is in contrast to its well-defined role
in facilitating spread and transmission of vaccinia virus (Frischknecht et al., 1999) suggesting that
WASL is important for different lifecycle stages for different viruses. In addition to the known interac-
tions between NCK1 and WASL, TNK2 has been reported to phosphorylate WASL
(Yokoyama et al., 2005). Consistent with these data, our genetic epistasis analysis and ectopic
trans-complementation data (Figure 3A–D) demonstrated that these three genes function in a path-
way in the context of picornavirus infection. Furthermore, biochemical and biophysical data demon-
strated direct interaction of NCK1 with both TNK2 and WASL. Previous studies have established a
clear role for CDC42 in regulation of TNK2 and WASL (Rohatgi et al., 2000; Prieto-Echagu¨e and
Miller, 2011), and inhibition of CDC42 resulted in reduced EMCV infection.
We explored the mechanism by which TNK2 and WASL act regarding picornavirus infection.
TNK2 KO1 cells were partially defective in EMCV internalization. In contrast, internalization was not
affected in WASL KO cells, suggesting WASL functions in one or more steps downstream of virus
internalization. In the absence of either TNK2 or WASL, EMCV particles continued to accumulate in
early endosomes at 30 min post infection in contrast to control cells, demonstrating a role for both
genes in endosomal trafficking. Notably, sid-3, the C. elegans orthologue of TNK2, is important for
endosomal trafficking of RNA molecules (Jose et al., 2012). Thus, one possibility is that the delay in
release from the early endosomes contributes to the reduction in EMCV infection in both TNK2 and
WASL KO cells. However, it is uncertain whether this observed accumulation in early endosomes is
directly related to the reduced levels of infection in these cells. In detailed studies of poliovirus,
most of the RNA genome is released from the virus particles by 20 min post internalization
(Brandenburg et al., 2007). Thus, additional studies are necessary to determine whether the accu-
mulated particles in the early endosomes still contain genomic RNA.
These data led us to the following model (Figure 8). TNK2 is in a pathway upstream of WASL and
NCK1. Because TNK2 deletion has a greater magnitude of impact than WASL or NCK1 deletion,
TNK2 must act on one or more additional step of the viral lifecycle than WASL and NCK1. Consistent
with this model, we demonstrated that TNK2 (but not WASL) is needed for virus internalization. In
addition, we propose that TNK2 activates WASL (presumably, but not necessarily, by phosphoryla-
tion and in a fashion mediated by NCK1 binding), which then affects a subsequent early step of the
EMCV lifecycle. Our data suggest that this step is linked to proper endocytic trafficking of the
incoming viral particles, which accumulated in early endosomes in both TNK2 and WASL deficient
cells to a greater extent than in control cells. The requirement for the WASL acidic domain, which is
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responsible for actin binding and nucleation, along with the sensitivity to the Arp2/3 inhibitor CK-
869, demonstrates that this process is actin dependent. One possibility is that regulated actin poly-
merization may be necessary to deliver endocytic vesicles to specific subcellular locations necessary
for productive infection.
Actin is critical for many cellular processes and due to its essentiality, is not a druggable target. In
this study, we identified a TNK2 and actin-dependent pathway necessary to promote virus infection
but does not appear to alter normal endocytosis. As cells lacking TNK2 and NCK1 are clearly viable,
as are mice lacking TNK2 and NCK1 (Bladt et al., 2003). These genes are potential antiviral targets
that could be disrupted by small molecules without compromising overall actin biology and survival
of the host.
It is becoming increasingly clear that there are additional, poorly defined stages of the picornavi-
rus lifecycle. A recent genetic screen identified PLA2G16 as an essential gene required for an early
stage of multiple picornaviruses at a step post binding, internalization, and pore formation
(Staring et al., 2017). Our study similarly suggests that WASL also acts after these stages. Further
study is needed to determine whether WASL acts at the same stage as PLA2G16 or at a distinct
step.
All four picornaviruses we tested were dependent on TNK2 and WASL. In contrast, viruses in
other families such as influenza A virus, parainfluenza 5 and adenovirus A5 were not affected by
absence of these genes, suggesting that picornaviruses may specifically depend on these host fac-
tors. PIV5 is known to enter cells by direct fusion at the cellular membrane and is not believed to uti-
lize endocytic vesicles (Porotto et al., 2012). The observed lack of dependence of PIV5 on TNK2 or
WASL is consistent with a potential role of TNK2 and WASL in modulating endocytic vesicle traffick-
ing. In contrast, picornaviruses such as poliovirus, CVB3, and EMCV are generally thought to utilize
clathrin independent endocytic vesicles for entry (Bergelson and Coyne, 2013), while influenza A
virus and adenovirus mostly rely on clathrin-mediated endocytosis for their entry (Yamauchi and
Figure 8. Model of TNK2, WASL, and NCK1 function in picornavirus infection.
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Helenius, 2013). The magnitude of the phenotypes did vary significantly among the tested picorna-
viruses, which is not surprising given the significant degree of divergence between these virus
genomes and differences in their entry requirements. Nonetheless, all four tested picornaviruses dis-
played different degree of dependence on this pathway. It will be important to test a wider range of
picornaviruses to determine exactly which taxa within the Picornaviridae are most reliant on these
genes. It will also be of great interest to test additional viruses from other families. The data sug-
gesting a role of WASL in Lassa virus infection (Oppliger et al., 2016) supports the notion that at
least some viruses in other virus families may also depend on one or more of these genes for
infection.
In recent years, multiple studies of host factors critical for picornavirus infection have utilized hap-
loid gene-trap screening or CRISPR screening in mammalian cell lines (Bazzone et al., 2019;
Staring et al., 2017; Kim et al., 2017). These studies have identified multiple host genes required
broadly for picornaviruses (Staring et al., 2017), as well as examples of genes required for specific
picornaviruses. For instance, ADAM9 was discovered as a potential receptor for EMCV by CRISPR
and gene trap screening (Bazzone et al., 2019; Baggen et al., 2019). Notably, the genes that we
identified by starting with the C. elegans Orsay virus genetic screen, TNK2, WASL, and NCK1, were
not identified as hits in any of the direct mammalian screens undertaken by others (Bazzone et al.,
2019; Staring et al., 2017; Kim et al., 2017). Thus, these approaches provide complementary
experimental strategies that, ideally in the long run, will lead to comprehensive understanding of
host factors necessary for virus infection.
Our study of TNK2 was driven by our identification in C. elegans of sid-3 as a host factor required
for Orsay virus infection (Jiang et al., 2017). sid-3 was originally identified in a genetic screen for
mutants defective in systemic spread of RNAi (Jose et al., 2012). That screening strategy also identi-
fied another C. elegans gene, sid-1, that is reported to transport dsRNA (Winston, 2002). A recent
study demonstrated that the mammalian orthologue of sid-1, SIDT2, has an evolutionarily conserved
function in transporting dsRNA that serves as a means of activating innate antiviral immunity in mice
(Nguyen et al., 2017). Those studies provide an example of the value of using the C. elegans model
system to guide insights into conserved functions with mammals. Here we demonstrated that TNK2,
the human orthologue of sid-3, has an evolutionarily conserved function to facilitate virus infection in
mammals. In C. elegans, Orsay virus infection is presumed to occur by fecal-oral transmission, as evi-
denced by its exclusive intestinal cell tropism (Franz et al., 2014). Deletion of sid-3 reduces Orsay
virus infection by >5 logs in vivo in the C. elegans host (Jiang et al., 2017). In the current study,
infection of mice lacking TNK2 by oral gavage, the analogous route of infection as for Orsay virus
infection of C elegans, led to increased survival of animals deficient in TNK2. These results clearly
demonstrate the functional parallels between sid-3 and TNK2 in their respective hosts in vivo. Thus,
our study has identified another example wherein novel insight in mammalian biology emerge from
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Cell culture and viruses
A549 cells were cultured and maintained in DMEM supplemented with 25 mM HEPES, 2 mM L-glu-
tamine, 1X non-essential amino acids, 10% Fetal bovine serum (FBS) and 100 u/ml antibiotics (peni-
cillin and streptomycin). 293T (human embryonic kidney), BHK-21 (Baby hamster kidney), RD
(rhabdomyosarcoma) and Hela cells were cultured and maintained in DMEM with 10% FBS. Haploid
cells (HAP1) were cultured and maintained in IMDM with 10% FBS. Mouse primary lung fibroblasts
were isolated by lung digestion as described (Edelman and Redente, 2018). Primary lung fibro-
blasts were derived from a Tnk2 homozygous knockout mouse (generated at the Genome Engineer-
ing and iPSC Center (GEiC) at Washington University as described below) and a homozygous wild
type littermate and were cultured in DMEM with 20% FBS. All cell lines used in this study were
tested negative for mycoplasma and their identity was indicated in the key resource table. Viruses
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were obtained from the following: EMCV VR-129 strain (Michael Diamond), coxsackie virus B3 Nancy
strain (Julie Pfeiffer), poliovirus Mahoney strain (Nihal Altan-Bonnet), influenza A virus WSN strain
(H1N1) (Adrianus Boon), adenovirus A5 (David Curiel), enterovirus D68 (ATCC), parainfluenza virus
(Robert A. Lamb), GFP-EMCV and GFP-CVB3 (Frank J. M. van Kuppeveld). EMCV was amplified on
BHK-21 cells; CVB3 and polio viruses were amplified on HeLa cells; and enterovirus D68 was ampli-
fied on RD cells.
Reagents and antibodies
a-sarcin was purchased from Santa Cruz. 35S methionine and 35S cysteine were purchased from Per-
kin Elmer. Alexa FluorA647 succinimidyl ester was purchased from ThermoFisher Scientific. Inhibitors
were purchased from commercial vendors as follows: Aim-100 (Apexbio), Wiskostatin (Sigma), Dyna-
sore (Sigma), Pitstop-2 (Sigma), CK-869 (Sigma), Pirl1 (Hit2leads). Anti-EMCV mouse polyclonal anti-
bodies were provided by Michael Diamond. Anti-poliovirus antibodies were provided by Nihal
Altan-Bonnet. Other antibodies were obtained from commercial vendors as follows: Anti-coxsackie
virus B3 antibodies (ThermoFisher), Anti-adenovirus A5 antibodies (ThermoFisher), Anti-influenza A
virus NP antibodies (Millipore), Anti-TNK2 (A11) (Santa Cruz), Anti-WASL (Abcam and Sigma), Anti-
actin, clone C4 (Sigma), Anti-NCK1 (Millipore), enterovirus D68 Ab (GeneTex), Anti-HA (Thermo-
Fisher), Anti-Flag (GenScript), Anti-c-Myc (Invitrogen), Anti-double stranded J2 antibodies (Scicons).
Plasmid constructions
All primers and oligonucleotides used in this study are listed in the supplementary table. Single
guide RNA (sgRNA) oligonucleotides were synthesized by Integrated DNA Technologies (IDT).
sgRNA oligoes were annealed and cloned into Lenti-CRISPR V2 plasmid digested by BsmBI. TNK2
(pReceiver-TNK2) and WASL (pReceiver-WASL) ORF clones were obtained from GeneCopoeia.
NCK1 (pcDNA-NCK1) ORF clone was obtained from GenScript. Mutations in the sgRNA binding
sites were introduced by site-directed mutagenesis (Stratagene) according to the manufacturer’s
protocol. TNK2, WASL and NCK1 were subcloned into a Lentivirus expression vector pFCIV digested
with Asc1 and Age1. The FRET control plasmid C5V was obtained from Addgene. mVenus cassette
was subcloned into pcDNA-NCK1 and pReceiver-WASL. mCerulean cassette was subcloned into
pReceiver-TNK2. Myc tagged TNK2 and HA tagged WASL was generated by annealing of oligonu-
cleotides and then subcloned into the expression vector. GFP tagged TNK2 and WASL were subcl-
oned into a tetracycline promoter driven Lentivirus vector pCW57. Constitutive active WASL
constructs were generated by site-directed mutagenesis. Domain truncation was generated by over-
lapping PCR. In brief, to generate pFCIV-WASL DWH1, pFCIV-WASL DB, pFCIV-WASL DPRD, pFCIV-
WASL DGBD, and pFCIV-WASL DA, WASL fragments were amplified from the start of the gene to
the start of the truncation and from the end of the truncation to the end of the gene, and the frag-
ments were then joined by overlapping PCR. The resulting product was digested by AgeI and AscI
and ligated into Lentivirus expression vector pFCIV that were cut by the same restriction enzymes.
Lentivirus production and cell transduction
800 ng of Lenti CRISPR V2 plasmids or pFCIV plasmids or pCW57 plasmids were transfected with
800 ng pSPAX2 and 400 ng pMD2.G into 293 T cells using Lipofectamine 2000 according to the
manufacturer’s protocol. Cell culture supernatant was harvested two days post transfection and
stored at  80˚C. For transduction, A549 cells were seeded one day before transduction. Cells were
spin transfected with lentivirus and 8 mg/ml of polybrene at MOI 5. Two days after transduction, cells
were passaged and either selected under corresponding antibiotics or fluorescently sorted through
flow cytometry.
CRISPR genome editing
A549 naı¨ve cells were transduced by lentiviruses that express the corresponding sgRNA and Cas9
protein. Transduced cells were passaged two days later and then selected with 2 mg/ml puromycin
for 7 days. Cells were passaged once during this selection. Clonal selection was performed through
limiting dilution in 96-well plates. After two weeks, single cell clones were picked and expanded in
24-well plates. The desired genome editing was identified by a restriction enzyme digestion-based
genome typing assay. Genome edited clonal cells were further sequenced by Sanger sequencing to
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define the precise genome editing event. Detection of a homozygous 28 bp (base pair) deletion
allele of TNK2 defined TNK2 KO1 and detection of a 25 bp deletion allele and 137 bp deletion allele
of TNK2 defined TNK2 KO2. Identification of a 1 bp insertion allele and a 2 bp deletion allele of
WASL defined WASL KO. An insertion allele of 94 bp in NCK1 was observed and this defined NCK1
KO. TNK2 KO1, WASL KO and NCK1 KO were used in all experiments except places specified using
other cells.
For homologous template-directed DNA repair through CRISPR genome editing, assembled
CRISPR RNP were transfected into A549 cells with single stranded oligodeoxynucleotide (ssODN) as
described (Jacobi et al., 2017). In brief, Alt-R S.p. Cas9 nuclease 3NLS protein, Alt-R CRISPR-Cas9
crRNA designed to target the deleted TNK2 KO1 genomic region, Alt-R CRISPR-Cas9 ATTO 550
tagged tracrRNA and ssODN were purchased from IDT. A549 cells were seeded into 12-well plates
one day before transfection. Equal molar crRNA and tracrRNA were annealed by heating to 95˚C for
5 min and then cooled to room temperature. RNP was assembled by combing equal molar ratio of
annealed cr-tracrRNA with Cas9 nuclease protein in opti-MEM. RNP was then transfected with
ssODN into A549 cells by lipofectamine CRISPR-MAX according to the manufacturer’s protocol. 24
hr after transfection, ATTO 550 positive cells were FACS sorted individually into 96-well plates. Sin-
gle cell colonies were expanded one week after sorting and genotyped with a restriction enzyme-
based genotyping assay. Template-directed DNA repair was finally confirmed by both Sanger and
PCR product deep sequencing.
For generation of gene double or triple knockout cells, the same CRISPR RNP transfection
method was used as homologous template-directed DNA repair using corresponding crRNA
designed to target genes with ssODN omitted. A double knockout of NCK1 and WASL was gener-
ated by CRISPR-Cas9 genome editing of the NCK1 locus in the WASL KO cells. A double knockout
of WASL and TNK2, a double knockout of NCK1 and TNK2, and a triple knockout of WASL, NCK1
and TNK2 were generated by CRISPR-Cas9 genome editing of the WASL locus and NCK1 locus in
the TNK2 KO1 cells. Genome editing events were screened by a restriction enzyme digestion-based
genotyping assay.
EMCV virus labeling and infection for imaging
EMCV was amplified in BHK-21 cells and purified according to previous publications
(Brandenburg et al., 2007; Staring et al., 2017). Virus labeling was performed with Alexa
FluorA647 succinimidyl ester in a 1:10 molar ratio and was then purified through Nap-5 desalting
column (GE Healthcare). Labeled viruses were aliquoted and stored at  80˚C. For EMCV entry imag-
ing analysis, A549 cells were seeded at 3000 cells per well in an 18-well IBD imaging slide chamber
one day before infection. The next day, cells were washed once with serum free DMEM and then
inoculated with labeled EMCV virus at an MOI of 20 on ice for one hour. Cells were washed three
times with ice-cold PBS after on ice binding. Cells were then fixed with 4% paraformaldehyde for 15
min at room temperature or cells were switched to 37˚C incubation with complete medium for inter-
nalization. After incubation with complete medium for 30 min, cells were then washed once with
PBS and fixed with 4% paraformaldehyde. Fixed cells were mounted in IBD mounting medium for
image analysis. For GFP-TNK2 and GFP-WASL localization with labeled EMCV virus imaging, live cell
experiment was performed in an 18-well IBD imaging slide in a temperature-controlled imaging
chamber.
EMCV virus binding and internalization assay
A549 cells were seeded at 1  105 cell per well in a 24-well plate one day before the assay. Cells
were chilled on ice for 30 min and then washed with ice-cold DMEM before inoculation. EMCV was
diluted in ice-cold DMEM with 0.1% BSA and then inoculated at an MOI of 20 in 250 ml of DMEM
per well of 24-well plate. Viruses were allowed to bind on ice for one hour. For virus binding experi-
ments, cells were washed three times with ice-cold PBS and then lysed in 350 ml Trizol reagent. For
virus internalization assay using trypsinization, experiments were performed as described previously
for WNV and AAV (Berry and Tse, 2017; Hackett et al., 2015). In brief, after one hour of binding,
the virus inoculum was removed and pre-warmed complete medium was added onto cells. Cells
were incubated in a 37˚C water bath for 30 min to allow for virus internalization. After incubation,
cells were washed three times with ice-cold PBS and then trypsinized for 6 min to remove surface
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bound virus. Trypsinized cells were then washed again three times and then spin at 300 g for 5 min.
Cell pellets were lysed in 350 ml Trizol reagents. RNA was extracted using the 96-well Zymo RNA
easy column extraction according to the manufacturer’s protocol. Viral RNA was quantified by one
step reverse transcription quantitative real-time PCR with an EMCV assay probe (Primers: forward
5’-CGATCACTATGCTTGCCGTT-3’; reverse 5’-CCCTACCTCACGGAATGGG-3’; Taqman probe 5’
FAM-AGAGCCGATCATATTCCTGCTTGCCA-3’). Fold change was converted from delta delta Ct of
an internal control assay by RPLP0 (Ribosomal protein lateral stalk subunit P0). For labeled EMCV,
internalization was performed the same way, after trypsinization and washing, cells were fixed in 4%
paraformaldehyde for 15 min at room temperature and then washed twice with P2F (PBS with 2%
Fetal bovine serum). Cells were finally resuspended in P2F and analyzed by MACS flow cytometry.
FACS assay
A549 cells were seeded one day before infection into 96-well plates. Approximately, 16 hr after
seeding, cells were infected by EMCV at an MOI of 1. One hour after infection, the inoculum was
removed and cells were cultured in DMEM with 2% FBS. 10 hr post infection, cells were trypsinized
and fixed with 4% paraformaldehyde. Fixed cells were then permeabilized with perm buffer (1 g
Saponin, 10 ml HEPES, 0.025% Sodium Azide in 1L HBSS) for 15 min. After permeabilization, cells
were incubated with primary antibodies for one hour and then washed twice before incubation with
fluorescently conjugated secondary antibodies. After one hour of secondary antibody incubation,
cells were washed three times with perm buffer and then resuspended with 70 ml of FACS buffer
P2F (PBS with 2% fetal bovine serum). Infected cells were then analyzed and quantified through
MACS flow cytometry (Miltenyi Biotec). FACS analysis of infection by CVB3, polio, enterovirus D68,
adenovirus and influenza virus on either A549 or Hap1 cells were performed the same as EMCV
infection, except that cells were harvested 8 hr post infection for CVB3, adenovirus, enterovirus D68
and influenza virus, and 6 hr post infection for poliovirus.
Multistep growth analysis for EMCV and Polio virus
For multistep growth analysis, A549 or Hap1 cells were infected by EMCV at an MOI of 0.01. One
hour after inoculation, cells were washed five times with serum free DMEM and were then cultured
in DMEM or IMDM with 2% FBS. Culture supernatant was collected at time 0, 6, 12, 24, 36, and 48
hr post infection. Viruses released in the culture supernatant were titrated on BHK-21 cells by plaque
assay. For polio virus multi-step growth titration, A549 or Hap1 cells were infected by virus at MOI
0.01 and culture supernatant were collected. Released viruses were titrated on HeLa cells by plaque
assay. For Coxsackie B3 virus multi-step growth titration, A549 cells were infected by virus at MOI
0.01 and culture supernatant were collected at time 0, 6, 12, 24, 36, and 48 hr post infection.
Released viruses were titrated on HeLa cells by plaque assay.
EMCV genomic RNA transfection
EMCV genomic RNA was extracted from pelleted virions by phenol chloroform extraction. For RNA
transfection, A549 cells (gene knockouts and control) were seeded into 24-well plate at 1  105 cells
per well. 16 hr after seeding, cells were transfected with 1.6 mg EMCV RNA by Lipofectamine 3000
according to the manufacturer’s protocol. Cell culture supernatant was collected at 10 hr post trans-
fection and was then titrated on BHK-21 cells by plaque assay.
Co-immunoprecipitation and western blot
Flag C-terminal tagged NCK1 was transfected with HA N-terminal tagged WASL or with Myc N-ter-
minal tagged TNK2 into 293 T cells. 48 hr after transfection, cells were lysed in IpLysis buffer (Invitro-
gen). Protein concentrations were quantified by BCA assay. 500 mg protein lysates were incubated
with 2 mg of anti-flag antibodies at 4˚C for overnight for immunoprecipitation. After antibody bind-
ing, the immuno-complex was incubated with protein A/G magnetic beads for one hour at room
temperature. The beads were washed and proteins bound to antibodies were eluted according to
the manufacture’s protocol (Invitrogen). Protein samples were prepared with 4X NuPAGE sample
buffer (Invitrogen) and then resolved on 4–12% NuPAGE gel. Proteins were transferred to a PVDF
membrane and then blocked with 5% skim milk. Primary antibodies were incubated in 5% milk for
overnight at 4˚C. After three washes with PBST (PBS with 0.3% of tween-20), corresponding HRP
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conjugated secondary antibodies were incubated in 5% milk at room temperature for 1 hr. The
membrane was washed five times with PBST and was then developed with chemiluminescent sub-
strate for 5 min and then imaged using a Bio-Rad chemiluminescence imager.
a-Sarcin pore forming assay
A549 cells were seeded at 3.6  104 per well of a 48-well plate. The next day, cells were washed
once with PBS and then incubated with methionine and cysteine free DMEM for one hour. Subse-
quently, cells were inoculated with EMCV virus at an MOI of 50 on ice for one hour. Inoculum were
then removed and cells were washed three times with ice cold PBS. Cells were then incubated with
100 mg/ml a-sarcin diluted in methionine and cysteine free DMEM for 90 min at 37˚C. After a-sarcin
treatment, cells were pulsed with 7.4 MBq 35S methionine and 35S cysteine in DMEM for 20 min.
Next, cells were washed four times with ice cold PBS and then lysed with SDS sample buffer. Pro-
teins were resolved on 7.5% SDS-PAGE gel and then dried on a Bio-Rad gel dryer. Dried gels were
exposed to a phosphorimager overnight and then scanned by Fuji IFA imaging system. As an inter-
nal loading control, a parallel SDS-PAGE gel was run and then proteins were transferred to PVDF
membrane and blotted with anti-actin antibodies.
Immunofluorescence assay
For EMCV co-localization with EEA1 marker, A549 cells were seeded at 3000 cells per well in an 18-
well IBD imaging slide chamber one day before infection. The next day, cells were washed once with
serum free DMEM and then inoculated with labeled EMCV virus at an MOI of 20 on ice for one hour.
Cells were washed three times with PBS after on ice binding. Cells were then switched to 37˚C incu-
bation with complete medium for internalization at indicated time. After incubation with complete
medium for different time, cells were then washed once with PBS and fixed with 4% paraformalde-
hyde for 10 min. Fixed cells were then permeabilized with 0.2% saponin for 10 min at room tempera-
ture and subsequently blocked with IFA blocking buffer (10% goat serum, 0.05% saponin in PBS) at
room temperature for 30 min. Cells were then incubated with EEA1 antibodies at 1:100 dilution in
blocking buffer overnight with shaking. Cells were washed three times with PBS and then incubated
with secondary antibodies at room temperature for 1 hr. After incubation, cells were washed once
with PBS and then incubated with Hoechst at 1:1000 dilution for 10 min at room temperature. Cells
were washed three time with PBS and mounted in IBD mounting medium for image analysis. For
dsRNA immunostaining in EMCV infected cells, the same procedure was performed as EEA1 immu-
nostaining except that 0.1% Triton was used instead of Saponin.
Confocal imaging and FRET analysis
Cells on slides or in an IBD imaging slide chamber were examined on a Zeiss airy scan confocal
microscope (LSM 880 II). A Plan Apochromat 63X, 1.4-numerical-aperture oil objective lens (Carl
Zeiss, Germany) was used to image labeled virus infection. For FRET analysis, 293 T cells were
seeded on coverslips and transfected with FRET pairs, mCerluean tagged TNK2 with mVenus tagged
NCK1 and mCerulean tagged WASL with mVenus tagged NCK1 respectively. 24 hr post transfec-
tion, cells were fixed in 4% paraformaldehyde and mounted on slides. Cells were imaged on a Zeiss
airy scan confocal with a Plan Apochromat 100X, 1.4-numerical-aperture oil objective lens. Acceptor
photo bleach was performed with 80% laser intensity of the imaging channel. Images were taken
before and after photo bleach and FRET efficiency were calculated after image acquisition on Zen
pro software (Carl Zeiss, Germany). For quantification of colocalization, image analysis was per-
formed using Volocity software V6.3 (PerkinElmer). In brief, virus pixels were automatically detected
in the red channel by Volocity with a particle size filter of no less than 25 pixels, colocalization were
detected by intersection pixels of the red channel and green channel. Percent of colocalization was
determined by dividing the colocalized intersection pixels by the total virus pixels. Pearson correla-
tion coefficient of EMCV and EEA1 was determined for each image using Volocity by setting a
threshold of each channel above background.
Transmission electron microscopy
EMCV was incubated with A549 cells (wild type, TNK2 KO and WASL KO) at an MOI of 20 for 1 hr
on ice. Cells were then washed with serum free DMEM and incubated with A549 culture media (2%
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FBS) for 6 hr. Infected cells were washed with PBS and fixed with 2% paraformaldehyde, 2.5% glutar-
aldehyde (Polysciences Inc, Warrington, PA) in 100 mM cacodylate buffer for 1 hr at room tempera-
ture. Next, cells were scraped from plates using a rubber cell scraper and cell pellets were
embedded in agarose. Agarose embedded cell pellets were post-fixed in 1% osmium tetroxide (Pol-
ysciences Inc) for 1 hr, then rinsed extensively in dH20 prior to en bloc staining with 1% aqueous ura-
nyl acetate (Ted Pella Inc, Redding, CA) for 1 hr. Following several rinses in dH20, samples were
dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella Inc). Sections
of 95 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica Microsystems Inc, Bannockburn,
IL), stained with uranyl acetate and lead citrate, and viewed on a JEOL 1200EX transmission electron
microscope (JEOL USA, Peabody, MA) equipped with an AMT eight mega-pixel digital camera
(Advanced Microscopy Techniques, Woburn, MA).
In vivo infection experiments
Animal experiments were conducted under the supervision of Department of Comparative Medicine
at Washington University in St. Louis. All animal protocols were approved by the Washington Univer-
sity Institutional Animal Care and Use Committee (Protocol #20170194 and #20180289). Tnk2 knock-
out mice were generated in the C57BL/6 background by CRISPR-Cas9 genome editing at the
Genome Engineering and iPSC Center (GEiC) at Washington University. All animals were housed in
the pathogen-free barrier. Age-matched animals with mixed gender (6–8 weeks old, 5 females and
six males for Tnk2 knockout, 2 females and five males for wild type littermates) were infected with 1
 107 PFU of EMCV (two doses at day 0 and day 1) via oral gavage according to previous publica-
tion (Wang et al., 2015). Infected mice were monitored for 3 weeks for all experiments. For virus
titration in infected mouse tissues, whole brain and heart were harvested at day four post virus
gavage (16 Tnk2 knock out and 14 wild type male mice). Tissues were weighed and a 1:5 wt to vol-
ume ratio of PBS was added to tissue sample. Tissues were homogenized by bead beating for 1 min
on a MagNALyzer bead beater, cool down for 2 min on ice and then another minute for bead beat-
ing. Tissue homogenates were centrifuged at 13,000 g for 5 min and supernatant were collected for
plaque assay on BHK-21 cells.
Statistical analysis
For statistical analysis, Student T-test was performed on the average values from three replicates. All
data shown with statistics are representative of at least two independent experiments. Log-rank test
and Mann Whitney test were done in Graphpad Prism V7. Statistical significance is indicated as
below: NS: no statistical significance, *: p<0.05, **: p<0.01, ***: p<0.001, ****: p<0.0001, *****:
p<0.00001.
Acknowledgements
This work was supported in part by National Institutes of Health R01 AI134967.
We thank Adrianus Boon, Skip Virgin, Celeste Morley and John Cooper for helpful discussions.
We thank Rong Zhang and Michael S Diamond for access to FACS instrumentation. FRET experi-
ments were performed at the Washington University Center for Cellular Imaging (WUCCI) supported
by Washington University School of Medicine, The Children’s Discovery Institute of Washington Uni-
versity and St. Louis Children’s Hospital (CDI-CORE-2015–505) and the Foundation for Barnes-Jewish
Hospital (3770). We thank Wandy Beatty for assistance with electron microscopy and laser scanning
confocal. We thank the Genome Engineering and iPSC Center (GEiC) at the Washington University
in St. Louis for their sgRNA validation and genotyping services for generating the Tnk2 knockout
mouse. We thank the flow cytometry core at Department of Pathology and Immunology, Washing-
ton University School of Medicine for assisting cell sorting. We thank Tim Schaff and Darren Kreamal-
meyer for assistance with mouse breeding.
Jiang et al. eLife 2019;8:e50276. DOI: https://doi.org/10.7554/eLife.50276 25 of 29
Research article Microbiology and Infectious Disease
Additional information
Funding
Funder Grant reference number Author
National Institutes of Health R01 AI134967 David Wang
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
Hongbing Jiang, Conceptualization, Resources, Data curation, Software, Formal analysis, Supervi-
sion, Validation, Investigation, Visualization, Methodology, Project administration; Christian Leung,
Data curation, Formal analysis, Validation, Investigation, Methodology; Stephen Tahan, Data cura-
tion, Software, Formal analysis, Validation, Investigation, Methodology; David Wang, Conceptualiza-






Animal experimentation: Animal experiments were conducted under the supervision of Department
of Comparative Medicine at Washington University in St. Louis. All animal protocols were approved
by the Washington University Institutional Animal Care and Use Committee (Protocol #20170194
and #20180289).





. Supplementary file 1. Primers and oligonucelotides used in this study.
. Transparent reporting form
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files.
Source data files were provided.
References
Adamovich DA, Nakamura F, Worth A, Burns S, Thrasher AJ, Hartwig JH, Snapper SB. 2009. Activating
mutations of N-WASP alter Shigella pathogenesis. Biochemical and Biophysical Research Communications 384:
284–289. DOI: https://doi.org/10.1016/j.bbrc.2009.04.050, PMID: 19379711
Baggen J, Thibaut HJ, Hurdiss DL, Wahedi M, Marceau CD, van Vliet ALW, Carette JE, van Kuppeveld FJM.
2019. Identification of the Cell-Surface protease ADAM9 as an entry factor for encephalomyocarditis virus.
mBio 10:e01780-19. DOI: https://doi.org/10.1128/mBio.01780-19, PMID: 31409686
Bazzone LE, King M, MacKay CR, Kyawe PP, Meraner P, Lindstrom D, Rojas-Quintero J, Owen CA, Wang JP,
Brass AL, Kurt-Jones EA, Finberg RW. 2019. A disintegrin and metalloproteinase 9 domain (ADAM9) Is a major
susceptibility factor in the early stages of encephalomyocarditis virus infection. mBio 10:e02734-18.
DOI: https://doi.org/10.1128/mBio.02734-18, PMID: 30723129
Bergelson JM, Coyne CB. 2013. Picornavirus entry. Advances in Experimental Medicine and Biology 790:24–41.
DOI: https://doi.org/10.1007/978-1-4614-7651-1_2, PMID: 23884584
Jiang et al. eLife 2019;8:e50276. DOI: https://doi.org/10.7554/eLife.50276 26 of 29
Research article Microbiology and Infectious Disease
Berry GE, Tse LV. 2017. Virus binding and internalization assay for Adeno-associated virus. Bio-Protocol 7:e2110.
DOI: https://doi.org/10.21769/BioProtoc.2110, PMID: 29226179
Bladt F, Aippersbach E, Gelkop S, Strasser GA, Nash P, Tafuri A, Gertler FB, Pawson T. 2003. The murine nck
SH2/SH3 adaptors are important for the development of mesoderm-derived embryonic structures and for
regulating the cellular actin network. Molecular and Cellular Biology 23:4586–4597. DOI: https://doi.org/10.
1128/MCB.23.13.4586-4597.2003, PMID: 12808099
Brandenburg B, Lee LY, Lakadamyali M, Rust MJ, Zhuang X, Hogle JM. 2007. Imaging poliovirus entry in live
cells. PLOS Biology 5:e183. DOI: https://doi.org/10.1371/journal.pbio.0050183
Carthy CM, Granville DJ, Watson KA, Anderson DR, Wilson JE, Yang D, Hunt DW, McManus BM. 1998. Caspase
activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells.
Journal of Virology 72:7669–7675. PMID: 9696873
Coyne CB, Shen L, Turner JR, Bergelson JM. 2007. Coxsackievirus entry across epithelial tight junctions requires
occludin and the small GTPases Rab34 and Rab5. Cell Host & Microbe 2:181–192. DOI: https://doi.org/10.
1016/j.chom.2007.07.003, PMID: 18005733
Coyne CB, Bergelson JM. 2006. Virus-induced abl and fyn kinase signals permit coxsackievirus entry through
epithelial tight junctions. Cell 124:119–131. DOI: https://doi.org/10.1016/j.cell.2005.10.035, PMID: 16413486
Dodding MP, Way M. 2009. Nck- and N-WASP-Dependent Actin-Based motility is conserved in divergent
vertebrate poxviruses. Cell Host & Microbe 6:536–550. DOI: https://doi.org/10.1016/j.chom.2009.10.011
Donnelly SK, Weisswange I, Zettl M, Way M. 2013. WIP provides an essential link between nck and N-WASP
during Arp2/3-dependent actin polymerization. Current Biology 23:999–1006. DOI: https://doi.org/10.1016/j.
cub.2013.04.051, PMID: 23707428
Edelman BL, Redente EF. 2018. Isolation and characterization of mouse fibroblasts. Methods in Molecular
Biology 1809:59–67. DOI: https://doi.org/10.1007/978-1-4939-8570-8_5, PMID: 29987782
Ferna´ndez-Puentes C, Carrasco L. 1980. Viral infection permeabilizes mammalian cells to protein toxins. Cell 20:
769–775. DOI: https://doi.org/10.1016/0092-8674(80)90323-2
Franz CJ, Renshaw H, Frezal L, Jiang Y, Fe´lix MA, Wang D. 2014. Orsay, santeuil and le blanc viruses primarily
infect intestinal cells in Caenorhabditis nematodes. Virology 448:255–264. DOI: https://doi.org/10.1016/j.virol.
2013.09.024, PMID: 24314656
Frischknecht F, Moreau V, Ro¨ttger S, Gonfloni S, Reckmann I, Superti-Furga G, Way M. 1999. Actin-based
motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401:926–929. DOI: https://doi.org/
10.1038/44860, PMID: 10553910
Fujimoto Y, Ochi H, Maekawa T, Abe H, Hayes CN, Kumada H, Nakamura Y, Chayama K. 2011. A single
nucleotide polymorphism in activated Cdc42 associated tyrosine kinase 1 influences the interferon therapy in
hepatitis C patients. Journal of Hepatology 54:629–639. DOI: https://doi.org/10.1016/j.jhep.2010.07.021,
PMID: 21129804
Galisteo ML, Yang Y, Uren˜a J, Schlessinger J. 2006. Activation of the nonreceptor protein tyrosine kinase ack by
multiple extracellular stimuli. PNAS 103:9796–9801. DOI: https://doi.org/10.1073/pnas.0603714103,
PMID: 16777958
Galletta BJ, Chuang DY, Cooper JA. 2008. Distinct roles for Arp2/3 regulators in actin assembly and
endocytosis. PLOS Biology 6:e1. DOI: https://doi.org/10.1371/journal.pbio.0060001, PMID: 18177206
Glaser W, Skern T. 2000. Extremely efficient cleavage of eIF4G by picornaviral proteinases L and 2A in vitro.
FEBS Letters 480:151–155. DOI: https://doi.org/10.1016/S0014-5793(00)01928-1, PMID: 11034318
Grøvdal LM, Johannessen LE, Rødland MS, Madshus IH, Stang E. 2008. Dysregulation of Ack1 inhibits down-
regulation of the EGF receptor. Experimental Cell Research 314:1292–1300. DOI: https://doi.org/10.1016/j.
yexcr.2007.12.017
Hackett BA, Yasunaga A, Panda D, Tartell MA, Hopkins KC, Hensley SE, Cherry S. 2015. RNASEK is required for
internalization of diverse acid-dependent viruses. PNAS 112:7797–7802. DOI: https://doi.org/10.1073/pnas.
1424098112, PMID: 26056282
Howlin J, Rosenkvist J, Andersson T. 2008. TNK2 preserves epidermal growth factor receptor expression on the
cell surface and enhances migration and invasion of human breast Cancer cells. Breast Cancer Research 10:R36.
DOI: https://doi.org/10.1186/bcr2087, PMID: 18435854
Huber SA. 1994. VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells.
Journal of Virology 68:3453–3458. PMID: 7514674
Innocenti M, Gerboth S, Rottner K, Lai FP, Hertzog M, Stradal TE, Frittoli E, Didry D, Polo S, Disanza A, Benesch
S, Di Fiore PP, Carlier MF, Scita G. 2005. Abi1 regulates the activity of N-WASP and WAVE in distinct actin-
based processes. Nature Cell Biology 7:969–976. DOI: https://doi.org/10.1038/ncb1304, PMID: 16155590
Jacobi AM, Rettig GR, Turk R, Collingwood MA, Zeiner SA, Quadros RM, Harms DW, Bonthuis PJ, Gregg C,
Ohtsuka M, Gurumurthy CB, Behlke MA. 2017. Simplified CRISPR tools for efficient genome editing and
streamlined protocols for their delivery into mammalian cells and mouse zygotes. Methods 121-122:16–28.
DOI: https://doi.org/10.1016/j.ymeth.2017.03.021
Jiang H, Chen K, Sandoval LE, Leung C, Wang D. 2017. An evolutionarily conserved pathway essential for orsay
virus infection of Caenorhabditis elegans. mBio 8:e00940-17. DOI: https://doi.org/10.1128/mBio.00940-17,
PMID: 28874467
Jones S, Cunningham DL, Rappoport JZ, Heath JK. 2014. The non-receptor tyrosine kinase Ack1 regulates the
fate of activated EGFR by inducing trafficking to the p62/NBR1 pre-autophagosome. Journal of Cell Science
127:994–1006. DOI: https://doi.org/10.1242/jcs.136895, PMID: 24413169
Jiang et al. eLife 2019;8:e50276. DOI: https://doi.org/10.7554/eLife.50276 27 of 29
Research article Microbiology and Infectious Disease
Jose AM, Kim YA, Leal-Ekman S, Hunter CP. 2012. Conserved tyrosine kinase promotes the import of silencing
RNA into Caenorhabditis elegans cells. PNAS 109:14520–14525. DOI: https://doi.org/10.1073/pnas.
1201153109, PMID: 22912399
Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S, Ma¨urer AP,
Mu¨ller E, Wolff T, Rudel T, Meyer TF. 2010. Genome-wide RNAi screen identifies human host factors crucial for
influenza virus replication. Nature 463:818–822. DOI: https://doi.org/10.1038/nature08760, PMID: 20081832
Keszei M, Record J, Kritikou JS, Wurzer H, Geyer C, Thiemann M, Drescher P, Brauner H, Ko¨cher L, James J, He
M, Baptista MA, Dahlberg CI, Biswas A, Lain S, Lane DP, Song W, Pu¨tsep K, Vandenberghe P, Snapper SB,
et al. 2018. Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive. Journal of
Clinical Investigation 128:4115–4131. DOI: https://doi.org/10.1172/JCI64772, PMID: 30124469
Kim HS, Lee K, Bae S, Park J, Lee CK, Kim M, Kim E, Kim M, Kim S, Kim C, Kim JS. 2017. CRISPR/Cas9-mediated
gene knockout screens and target identification via whole-genome sequencing uncover host genes required for
Picornavirus infection. Journal of Biological Chemistry 292:10664–10671. DOI: https://doi.org/10.1074/jbc.
M117.782425, PMID: 28446605
Ko¨nig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB,
Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G,
Miraglia L, et al. 2010. Human host factors required for influenza virus replication. Nature 463:813–817.
DOI: https://doi.org/10.1038/nature08699, PMID: 20027183
Liu Y, Karaca M, Zhang Z, Gioeli D, Earp HS, Whang YE. 2010. Dasatinib inhibits site-specific tyrosine
phosphorylation of androgen receptor by Ack1 and src kinases. Oncogene 29:3208–3216. DOI: https://doi.org/
10.1038/onc.2010.103, PMID: 20383201
Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, Davis C, Mee CJ, Turek M, Gorke S, Royer C,
Fischer B, Zahid MN, Lavillette D, Fresquet J, Cosset FL, Rothenberg SM, Pietschmann T, Patel AH, Pessaux P,
et al. 2011. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral
therapy. Nature Medicine 17:589–595. DOI: https://doi.org/10.1038/nm.2341, PMID: 21516087
Madshus IH, Olsnes S, Sandvig K. 1984a. Requirements for entry of poliovirus RNA into cells at low pH. The
EMBO Journal 3:1945–1950. DOI: https://doi.org/10.1002/j.1460-2075.1984.tb02074.x, PMID: 6092049
Madshus IH, Olsnes S, Sandvig K. 1984b. Different pH requirements for entry of the two picornaviruses, human
rhinovirus 2 and murine encephalomyocarditis virus. Virology 139:346–357. DOI: https://doi.org/10.1016/0042-
6822(84)90380-5, PMID: 6097029
Mahajan NP, Whang YE, Mohler JL, Earp HS. 2005. Activated tyrosine kinase Ack1 promotes prostate
tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor wwox. Cancer Research 65:10514–
10523. DOI: https://doi.org/10.1158/0008-5472.CAN-05-1127, PMID: 16288044
Mahajan NP, Liu Y, Majumder S, Warren MR, Parker CE, Mohler JL, Earp HS, Whang YE. 2007. Activated Cdc42-
associated kinase Ack1 promotes prostate Cancer progression via androgen receptor tyrosine phosphorylation.
PNAS 104:8438–8443. DOI: https://doi.org/10.1073/pnas.0700420104, PMID: 17494760
Mahajan K, Challa S, Coppola D, Lawrence H, Luo Y, Gevariya H, Zhu W, Chen YA, Lawrence NJ, Mahajan NP.
2010. Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity. The Prostate
70:1274–1285. DOI: https://doi.org/10.1002/pros.21163, PMID: 20623637
Massaad MJ, Ramesh N, Geha RS. 2013. Wiskott-Aldrich syndrome: a comprehensive review. Annals of the New
York Academy of Sciences 1285:26–43. DOI: https://doi.org/10.1111/nyas.12049, PMID: 23527602
Melnick JL. 1983. Portraits of viruses: the picornaviruses. Intervirology 20:61–100. DOI: https://doi.org/10.1159/
000149376, PMID: 6313547
Nguyen TA, Smith BRC, Tate MD, Belz GT, Barrios MH, Elgass KD, Weisman AS, Baker PJ, Preston SP,
Whitehead L, Garnham A, Lundie RJ, Smyth GK, Pellegrini M, O’Keeffe M, Wicks IP, Masters SL, Hunter CP,
Pang KC. 2017. SIDT2 transports extracellular dsRNA into the cytoplasm for innate immune recognition.
Immunity 47:498–509. DOI: https://doi.org/10.1016/j.immuni.2017.08.007
Oppliger J, Torriani G, Herrador A, Kunz S. 2016. Lassa virus cell entry via dystroglycan involves an unusual
pathway of macropinocytosis. Journal of Virology 90:6412–6429. DOI: https://doi.org/10.1128/JVI.00257-16,
PMID: 27147735
Peterson JR, Bickford LC, Morgan D, Kim AS, Ouerfelli O, Kirschner MW, Rosen MK. 2004. Chemical inhibition
of N-WASP by stabilization of a native autoinhibited conformation. Nature Structural & Molecular Biology 11:
747–755. DOI: https://doi.org/10.1038/nsmb796, PMID: 15235593
Porotto M, Palmer SG, Palermo LM, Moscona A. 2012. Mechanism of fusion triggering by human parainfluenza
virus type III: communication between viral glycoproteins during entry. The Journal of Biological Chemistry 287:
778–793. DOI: https://doi.org/10.1074/jbc.M111.298059, PMID: 22110138
Prieto-Echagu¨e V, Gucwa A, Brown DA, Miller WT. 2010. Regulation of Ack1 localization and activity by the
amino-terminal SAM domain. BMC Biochemistry 11:42. DOI: https://doi.org/10.1186/1471-2091-11-42,
PMID: 20979614
Prieto-Echagu¨e V, Miller WT. 2011. Regulation of ack-family nonreceptor tyrosine kinases. Journal of Signal
Transduction 2011:1–9. DOI: https://doi.org/10.1155/2011/742372, PMID: 21637378
Rohatgi R, Ho HY, Kirschner MW. 2000. Mechanism of N-WASP activation by CDC42 and phosphatidylinositol 4,
5-bisphosphate. The Journal of Cell Biology 150:1299–1310. DOI: https://doi.org/10.1083/jcb.150.6.1299,
PMID: 10995436
Rohatgi R, Nollau P, Ho HY, Kirschner MW, Mayer BJ. 2001. Nck and phosphatidylinositol 4,5-bisphosphate
synergistically activate actin polymerization through the N-WASP-Arp2/3 pathway. Journal of Biological
Chemistry 276:26448–26452. DOI: https://doi.org/10.1074/jbc.M103856200, PMID: 11340081
Jiang et al. eLife 2019;8:e50276. DOI: https://doi.org/10.7554/eLife.50276 28 of 29
Research article Microbiology and Infectious Disease
Shen H, Ferguson SM, Dephoure N, Park R, Yang Y, Volpicelli-Daley L, Gygi S, Schlessinger J, De Camilli P. 2011.
Constitutive activated Cdc42-associated kinase (Ack) phosphorylation at arrested endocytic clathrin-coated pits
of cells that lack dynamin. Molecular Biology of the Cell 22:493–502. DOI: https://doi.org/10.1091/mbc.e10-07-
0637, PMID: 21169560
Staring J, von Castelmur E, Blomen VA, van den Hengel LG, Brockmann M, Baggen J, Thibaut HJ, Nieuwenhuis
J, Janssen H, van Kuppeveld FJ, Perrakis A, Carette JE, Brummelkamp TR. 2017. PLA2G16 represents a switch
between entry and clearance of Picornaviridae. Nature 541:412–416. DOI: https://doi.org/10.1038/
nature21032, PMID: 28077878
Stradal TE, Rottner K, Disanza A, Confalonieri S, Innocenti M, Scita G. 2004. Regulation of actin dynamics by
WASP and WAVE family proteins. Trends in Cell Biology 14:303–311. DOI: https://doi.org/10.1016/j.tcb.2004.
04.007, PMID: 15183187
Teo M, Tan L, Lim L, Manser E. 2001. The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a
binding motif shared by arrestin and other adaptors. Journal of Biological Chemistry 276:18392–18398.
DOI: https://doi.org/10.1074/jbc.M008795200, PMID: 11278436
Wang P, Zhu S, Yang L, Cui S, Pan W, Jackson R, Zheng Y, Rongvaux A, Sun Q, Yang G, Gao S, Lin R, You F,
Flavell R, Fikrig E. 2015. Nlrp6 regulates intestinal antiviral innate immunity. Science 350:826–830. DOI: https://
doi.org/10.1126/science.aab3145, PMID: 26494172
Winston WM. 2002. Systemic RNAi in C. Elegans requires the putative transmembrane protein SID-1. Science
295:2456–2459. DOI: https://doi.org/10.1126/science.1068836
Wolf YI, Kazlauskas D, Iranzo J, Lucı´a-Sanz A, Kuhn JH, Krupovic M, Dolja VV, Koonin EV. 2018. Origins and
evolution of the global RNA virome. mBio 9:e02329-18. DOI: https://doi.org/10.1128/mBio.02329-18,
PMID: 30482837
Yamauchi Y, Helenius A. 2013. Virus entry at a glance. Journal of Cell Science 126:1289–1295. DOI: https://doi.
org/10.1242/jcs.119685, PMID: 23641066
Yokoyama N, Lougheed J, Miller WT. 2005. Phosphorylation of WASP by the Cdc42-associated kinase ACK1:
dual hydroxyamino acid specificity in a tyrosine kinase. The Journal of Biological Chemistry 280:42219–42226.
DOI: https://doi.org/10.1074/jbc.M506996200, PMID: 16257963
Yokoyama N, Miller WT. 2003. Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. substrate
specificity, Authphosphorylation, and interaction with hck. The Journal of Biological Chemistry 278:47713–
47723. DOI: https://doi.org/10.1074/jbc.M306716200, PMID: 14506255
Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, Billis K, Cummins C, Gall A, Giro´n CG, Gil L,
Gordon L, Haggerty L, Haskell E, Hourlier T, Izuogu OG, Janacek SH, Juettemann T, To JK, Laird MR, et al.
2018. Ensembl 2018. Nucleic Acids Research 46:D754–D761. DOI: https://doi.org/10.1093/nar/gkx1098,
PMID: 29155950
Jiang et al. eLife 2019;8:e50276. DOI: https://doi.org/10.7554/eLife.50276 29 of 29
Research article Microbiology and Infectious Disease
